YDES
NASDAQ · Biotechnology
Yd Bio Ltd
$5.46
+0.04 (+0.74%)
Open$5.58
Previous Close$5.42
Day High$5.67
Day Low$5.40
52W High$25.00
52W Low$7.20
Volume—
Avg Volume11.6K
Market Cap563.26M
P/E Ratio—
EPS$-1.03
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 498.8K | 122.20M | 119.09M |
| Net Income | -1,385,621 | 29.08M | 25.78M |
| Profit Margin | -276.6% | 23.8% | 21.7% |
| EBITDA | -1,364,837 | 41.35M | 38.15M |
| Free Cash Flow | — | 33.20M | 25.74M |
| Rev Growth | — | +2.9% | +5.6% |
| Debt/Equity | 0.01 | 0.45 | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |